Serum CRP is one of the best-studied non-invasive biomarkers of inflammation in IBD (Sands 2015) while serum albumin is a negative acute-phase reactant widely applied to assess the inflammatory condition of the human body (Wang et al. 2022). The gene discussed is ALB; the disease is inflammatory bowel disease.